As the cost and complexities of drug development increase, so do the challenges of global clinical trials. Today’s sponsors must... View Article

Can you imagine working for months to ensure your clinical supply strategy is in place for your European studies, only... View Article

Bringing a new drug to market can be a heavy financial burden on any pharmaceutical company. It has become even... View Article

Recently, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) opened an investigation into a patient complaint of mould on... View Article

PCI Pharma Services has invested in state-of-the-art containment equipment and created a ‘Potent Passport’ philosophy to identify the specific handling... View Article

Making Clinical Trials More Effective By Keeping Focus On The Patient – A Q&A with Justin Schroeder, Executive Director, Marketing,... View Article

The Challenge and Opportunity of Distributing Temperature-Sensitive Biopharmaceuticals and Cell Therapies Distributing sensitive biopharmaceuticals and cell therapies is a complex... View Article

The journey from discovery laboratory to pharmacy shelf is long and arduous, particularly for highly potent APIs, which must be... View Article

Successfully managing the demands of cell therapy supply chains – addressing the unique complexity of an autologous therapy supply chain... View Article

A controlled substance is a drug or chemical whose manufacture, possession or distribution is highly regulated by the government and... View Article